UNIGE document Scientific Article
previous document  unige:98835  next document
add to browser collection

Human venous valve disease caused by mutations in FOXC2 and GJC2

Lyons, Oliver
Saha, Prakash
Seet, Christopher
Kuchta, Adam
Arnold, Andrew
Grover, Steven
Rashbrook, Victoria
Sabine, Amélie
show hidden authors show all authors [1 - 24]
Published in Journal of Experimental Medicine. 2017, vol. 214, no. 8, p. 2437-2452
Abstract Venous valves (VVs) prevent venous hypertension and ulceration. We report that FOXC2 and GJC2 mutations are associated with reduced VV number and length. In mice, early VV formation is marked by elongation and reorientation ("organization") of Prox1(hi) endothelial cells by postnatal day 0. The expression of the transcription factors Foxc2 and Nfatc1 and the gap junction proteins Gjc2, Gja1, and Gja4 were temporospatially regulated during this process. Foxc2 and Nfatc1 were coexpressed at P0, and combined Foxc2 deletion with calcineurin-Nfat inhibition disrupted early Prox1(hi) endothelial organization, suggesting cooperative Foxc2-Nfatc1 patterning of these events. Genetic deletion of Gjc2, Gja4, or Gja1 also disrupted early VV Prox1(hi) endothelial organization at postnatal day 0, and this likely underlies the VV defects seen in patients with GJC2 mutations. Knockout of Gja4 or Gjc2 resulted in reduced proliferation of Prox1(hi) valve-forming cells. At later stages of blood flow, Foxc2 and calcineurin-Nfat signaling are each required for growth of the valve leaflets, whereas Foxc2 is not required for VV maintenance.
PMID: 28724617
Full text
Article (Published version) (4.8 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group L'athérosclérose (665)
(ISO format)
LYONS, Oliver et al. Human venous valve disease caused by mutations in FOXC2 and GJC2. In: Journal of Experimental Medicine, 2017, vol. 214, n° 8, p. 2437-2452. https://archive-ouverte.unige.ch/unige:98835

90 hits

0 download


Deposited on : 2017-11-10

Export document
Format :
Citation style :